More biotech and health care stories
People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest
The findings come as federal regulators issued a warning about Paxlovid rebounds.
Moderna says it’s starting to work on a monkeypox vaccine
The Cambridge company is in the early stages of developing an mRNA vaccine for the viral disease that is spreading in the US and Europe.
Boston monkeypox patient had 200 contacts
Most were health care workers, and the risk to the general public remained low, the CDC said.
Internal analysis shows Black patients at Brigham faced more security calls
Researchers found that 2.8 percent of Black patients had security called on them, compared with 1.6 percent of white patients.
Experimental pill prompts some to regrow a nearly full head of hair
Lexington-based Concert Pharmaceuticals said its therapy could restore hair in up to 42 percent of people with a severe form of hair loss.
‘I feel like I’m failing him’: Mass. parents scramble to find formula for their infants as shortage continues
The situation is especially acute for parents rearing infants with milk, gluten, and other allergies, who require special formulas that are particularly scarce.
RI BUSINESS
Lifespan CEO: Failure of Lifespan-CNE merger was a factor in decision to step down
“It wasn’t the only factor, and quite frankly, it wasn’t the main factor. But it was a factor,” Dr. Timothy Babineau said. “When that got blocked, knowing what lies ahead, I thought it was time for a change for me.”
Monkeypox is not highly contagious, scientists say. So why is it suddenly in nine countries?
The Boston case is one of more than 100 confirmed and suspected cases across nine countries in Europe and North America.